🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06928441
Starting soon Not applicable

Non-invasive Vagus Nerve Stimulation and Sleep in Healthy Volunteers.

NCT06928441 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2025-04-30
Last updated
2025-04-15

Condition(s) studied

Sleep

Investigational drug(s) / intervention(s)

Transcutaneous Pulsed Electrical Stimulation (Device: WL-2103A)

Transcutaneous Pulsed Electrical Stimulation (Device: WL-2103A): The Transcutaneous Electrical Nerve Stimulator (TENS) creates electrical impulses from a 9VDC-battery whose continuous intensity rate can be controlled by the user. The alligator clip with 2 electrodes is placed on the tragus part of the ear (shown to be 45% innervated via auricular vagus nerve) to stimulate the vagus nerve with an adjustable peak intensity (0-80mA), a frequency of 2 - 250Hz and a pulse width of 30-260 µsec. The vagus nerve contains a mixture of different types of nerve fibres, which are organized into bundles (fascicles). The fibres vary in diameter and conduction velocity, with A-type fibres the largest and fastest and C-type fibres the smallest and slowest, with B-type fibres intermediate. During nerve stimulation, fibres are activated in order of size from the largest (A-type) to the smallest (C-type). It has been suggested that A-type fibres are mainly activated during the stimulation via auricular vagus nerve.

Study summary

Participants will be chosen at random to receive a 30-minute stimulation of a specialized nerve (called a vagus nerve). The aim of this study is to determine whether a battery-operated portable device (current adjustable) attached to the outer ears (tragus) makes one more likely to improve on their sleep and quality of daily life. Participants will visit the lab on 2 occasions (one with a stimulating device and one without), 3 weeks apart for detailed instruction on setting up the ear stimulation and sleep kit in their home. Researchers will compare the sleep results from a PSG sleep device from the 2 sessions to determine the effect, if any on sleep.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Male or female, aged ≥ 18 and \< 50 years. * In good health with no evidence of medical problems. * Ability to provide informed consent and willingness to comply with the study procedures. * Ability to use a battery operated electro-stimulating device attached to your ears for 30 minutes. * Ability to breathe through the nose comfortably and wear a sleep monitoring device. Exclusion Criteria: * Obesity (BMI \> 40 kg/m2). * Known history of heart, lung, kidney, or liver disease. * Diagnosis of asthma or sleep apnea. * Diagnosis of diabetes. * Current smoker. * Pregnancy or lactation due to the location of the sleep devices. * Resting heart rate \> 120 bpm. * Systolic BP \> 150, diastolic BP \> 90. * Presence of any other condition that, in the opinion of the PI, makes the individual unsuitable for participation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Unviersity of Calgary Calgary Alberta

More University of Calgary trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06928441 on ClinicalTrials.gov ↗ ← All trials in Canada